AemetisAlto Ingredients

Aemetis vs Alto Ingredients

Aemetis focuses on advanced biofuels and renewable natural gas with a heavy development-stage profile, while Alto Ingredients runs established ethanol production facilities with a more immediate comme...

Investment Analysis

Pros

  • Aemetis has shown revenue growth with $59.2 million in Q3 2025, up $7 million from the prior quarter driven by India Oil Marketing Company orders and higher ethanol prices and volumes.
  • The company is advancing a $30 million Mechanical Vapor Recompression system expected to increase cash flow by $32 million annually, enhancing operational efficiency.
  • Aemetis operates diversified segments including renewable natural gas, ethanol, and biodiesel in the US and India, positioning it for growth in low and negative carbon intensity products.

Considerations

  • Despite recent revenue growth, Aemetis has a relatively small market cap of approximately $144 million, indicating limited scale compared to larger energy peers.
  • The company’s P/E ratio is negative, reflecting ongoing losses and the inherent execution risks in its expansion projects and technology commercialization.
  • Aemetis operates in volatile renewable fuel markets and depends on regulatory policies and commodity prices, which pose macroeconomic uncertainties and cyclicality risks.

Pros

  • Alto Ingredients generated $933 million in revenue over the past twelve months, reflecting a substantial scale in specialty alcohols and renewable fuel markets.
  • The company serves diversified end markets including health, home, beauty, and food and beverage, reducing dependency on any single sector.
  • Recent analyst sentiment shows a strong buy rating with a significant price target upside, indicating positive market expectations for turnaround potential.

Considerations

  • Alto Ingredients reported a net loss exceeding $60 million in the latest twelve-month period, with losses more than doubling year-over-year, indicating strained profitability.
  • The stock price has declined significantly from its 52-week high, reflecting investor concerns around sustainability of revenue and earnings.
  • Revenue decreased by over 21% year-over-year, suggesting challenges in maintaining sales momentum amid competitive pressures and market fluctuations.

Buy AMTX or ALTO in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

AMTX
AMTX$2.27
vs
ALTO
ALTO$2.89